AARD · Aardvark Therapeutics, Inc.

NasdaqHealthcareBiotechnology

Aardvark Therapeutics Inc Is A Clinical-Stage Biopharmaceutical Company Focused On Developing Novel, Small-Molecule Therapeutics To Activate Innate Homeostatic Pathways For The Treatment Of Metabolic Diseases. It Is Focused On On Developing Selective Compounds, Targeting Bitter Taste Receptors (Tas2rs) For Hunger-Associated Conditions. Its Product Candidate, Ard-101, Is An Oral Gut-Restricted Small-Molecule Agonist Of Certain Tas2rs Expressed In The Gut Lumen For Which Have Initiated A Phase 3 Clinical Trial For Hyperphagia Associated With Pws.

HealthcareNasdaqUSLow Float

FLOAT

12.2M

FREE FLOAT %

56%

SHARES O/S

21.9M

MARKET CAP

$30.4M

EXCHANGE

Nasdaq

COUNTRY

AARD Catalyst History

No catalysts recorded for AARD yet

Day Trader Sniper hasn't classified a publishable catalyst for AARD yet. New events appear here as they're scored.

Be early on the next AARD spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

AARD · Aardvark Therapeutics, Inc.

AARD Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.